{"id":"AGY-FED-HEALTH-OTHER-020","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA","authority":"21 U.S.C. 822(e); 21 C.F.R. 1301.12; 21 C.F.R. 1307.03","instrument":"DEA-DC-030 (DEA087), letter extending the off-site take-home delivery flexibility to buprenorphine dispensed by opioid treatment programs","title":"Off site OTP delivery buprenorphine","dateIssued":"2020-04-21","effective":"2020-04-21","end":"During the public health emergency or until withdrawn or modified by DEA","startDate":"2020-04-21","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"addressees":["DEA-registered narcotic treatment programs"],"clause":"DEA is now extending the same flexibility to OTPs in how they deliver take-home doses of buprenorphine. As with methadone, DEA is temporarily allowing OTPs to regularly use the same off-site location to deliver take-home buprenorphine doses to their patients without separately registering that location with DEA, subject to the same conditions as expressed in the April 7 methadone guidance document.","enforcement":"Registration requirements under 21 U.S.C. 822(e) and 842","functions":["CL clinical dispensing","TR transport","CB patients"],"notes":"","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-030)(DEA087)_off_site_otp_delivery_buprenorphine_(esign).pdf","snapshot":"","fileExists":true,"fileBytes":184887,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-020","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-020","citation":"Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA, DEA-DC-030 (DEA087), letter extending the off-site take-home delivery flexibility to buprenorphine dispensed by opioid treatment programs (Apr. 21, 2020) (Ex. AGY-FED-HEALTH-OTHER-020)","stateName":"","related":["AGY-FED-HEALTH-OTHER-016","AGY-FED-HEALTH-OTHER-014","AGY-FED-HEALTH-OTHER-011","AGY-FED-HEALTH-OTHER-010"]}